India lowers AstraZeneca COVID-19 vaccine price for less than Rs 200 per dose
New Delhi: The Indian government has lowered the price at which it buys AstraZeneca's COVID-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.
Read also: AstraZeneca COVID-19 vaccine recommended in Germany for people over 65
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.